TE_30949
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MIRb |
|---|---|
| TE superfamily | L2-end |
| TE class | SINE |
| Gene | NPIPB8 |
| Class | Chimeric, Annoated |
| Coding | Non-coding |
| Tumor-specific score | 0.02 |
| Counts of samples | TCGA_tumor:30; TCGA_normal:2; GTEx:1795 |
| TSS | chr16(+):28638073 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_30949.1 | NPIPB8 | Chimeric | Non-coding | Non-coding | chr16(+):28638074,28638160,28638323,28638480,28648135,28648317,28651957,28652056,28652169,28652364,28656463,28656523,28656633,28656668,28658028,28658048 |
| teRNA_30949.2 | NPIPB8 | Annoated | Non-coding | Non-coding | chr16(+):28638074,28638150,28638323,28638480,28648135,28648317,28651957,28652056,28652169,28652364,28656463,28656523,28656633,28656668,28658028,28658048 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
